Even as President Donald Trump wages a very public fight against diversity, equity and inclusion (DEI) initiatives in the ...
A former employee of Stanford University was found guilty of accessing a clinical research database for a multisite breast ...
As we enter 2025, the confluence of scientific advancement, market opportunity and industry validation suggests women's ...
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY) announced today that the U.S. Food and Drug Administration (FDA) has approved ...
Roche’s U.S. biotech subsidiary Genentech has wiped its website of past diversity reports as the company’s diversity and ...
A jury found Naheed Mangi replaced patient medical data with erroneous information, insults about former boss.
Genentech and Novartis have teamed up with Food Allergy Research & Education (FARE) to enhance the safety of children with ...
The campaign is based on the results of a survey that reveals the experiences of patients and caregivers in their communities ...
Roche’s subsidiary Genentech has shared positive Phase III data with the US Food and Drug Administration (FDA) as the company targets the billion-dollar lupus market for its CD20-targeting drug Gazyva ...
FDA Approves Genentech’s Evrysdi Tablet as First and Only Tablet for Spinal Muscular Atrophy (SMA)
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that the U.S. Food and Drug Administration (FDA) has approved a New ...
Nykode Therapeutics AS (VACBF) reports significant revenue increase and strategic initiatives amid challenges in their Q4 2024 earnings call.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback